It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
US $ 555,000 invested by Wavemaker Partners in pre-seed round
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
The sale is expected to close in the first quarter of 2022
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
In the interim, Deepak Khanna will lead Human Health International.
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Subscribe To Our Newsletter & Stay Updated
